Clinical Trials Directory

Trials / Unknown

UnknownNCT05902000

Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion

Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion: A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
222 (estimated)
Sponsor
Xueli Cai · Other Government
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

1. To evaluate whether stent implantation on the ipsilateral extracranial segment, after intracranial thrombectomy successful recanalization compared with balloon angioplasty (eTICI≥2b\_50) for acute anterior circulation tandem lesions within 24h of onset, can improve neurological functional outcomes(mRS≤2). 2. To evaluate whether stent implantation on the ipsilateral extracranial segment, after intracranial thrombectomy successful recanalization compared with balloon angioplasty (eTICI≥2b\_50) for acute anterior circulation tandem lesions within 24h of onset, can increase the risk of symptomatic intracranial hemorrhage.

Detailed description

The study was a prospective, randomized, open-label, blinded end-point Clinical Trial. Subjects were randomized 1:1 according to inclusion and exclusion criteria into a trial group (acute phase extracranial vascular stent implantation group) and a control group (acute phase non-extracranial vascular stent implantation group). Randomization was performed for 90d and 180d for the follow-up to collect primary and secondary efficacy and safety indicators.

Conditions

Interventions

TypeNameDescription
DEVICECarotid StentingEmergent carotid stenting will be performed if the patient is randomized in the intervention arm. The order to treat (head first or neck first) the extracranial carotid artery lesion will be left to the interventionist discretion.
PROCEDUREThrombectomyIntracranial thrombectomy is an endovascular procedure. In the experimental group, thrombectomy will be completed with extracranial carotid stenting.
DRUGDual antiplatelet treatmentDual antiplatelet therapy is administered after 24 hours of imaging follow-up excluding intracranial hemorrhagic complications. Aspirin Enteric-coated Tablets (Bay Aspirin) 100mg once a night+Clopidogrel Sulfate Tablets (Plavix) 75mg once daily. If there is no contraindication, maintain for more than 1 month, then adjust the dosing regimen according to the guidelines.
DRUGIntraoperative Drug TreatmentTirofiban is used as an adjunct to endovascular therapy. The currently recommended dosing regimen is a combined intra-catheter arterial administration of a loading dose of 0.4 μg/(kg-min) for 30 min (total dose not to exceed 1 mg), followed by intravenous pumping of 0.1μg/(kg-min) for 24-48h, and adjustment of dosing in conjunction with CT.

Timeline

Start date
2023-06-14
Primary completion
2025-06-01
Completion
2025-12-01
First posted
2023-06-13
Last updated
2023-06-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05902000. Inclusion in this directory is not an endorsement.